C

Castle Creek Biosciences, Inc.

35 employees

Castle Creek Biosciences is focused on developing commercializing novel, personalized gene therapies for rare skin disorders.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Dermatology
Clinical research
Bioscience
Pharmaceutical
Personalized medicine
Drug development
Orphan drug
Localized Scleroderma
Rare disease
Genetics
Life sciences
Biopharma
Gene therapy
Pediatric disease
Life Science
Epidermolysis Bullosa

Date founded

2020

Funding rounds raised

Total raised

$113M

from 6 investors over 6 rounds

C

Castle Creek Biosciences, Inc. raised $113M on May 2, 2022

Investors: Paragon Biosciences and Valor Equity Partners

C

Castle Creek Biosciences, Inc. raised $20M on March 25, 2020

Investors: Horizon Technology Finance

C

Castle Creek Biosciences, Inc. raised $55M on March 25, 2020

Investors: Valor Equity Partners and Paragon Biosciences

C

Castle Creek Biosciences, Inc. raised $72M on October 19, 2018

Investors: Valor Equity Partners

FAQ